Patent US4780488A successfully refreshed from Google Patents.
US4780488A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Wettable, flexible, oxygen permeable, substantially non-swellable contact lens containing polyoxyalkylene backbone units, and use thereof
Assignee: Novartis Corp
•
Filing: 1987-06-05
•
Granted: 1988-10-25
•
Expires: 2007-06-05
Abstract
Abstract Contact lenses which are optically clear, wettable, flexible, of high oxygen permeability and substantially non-swellable in the aqueous ocular environment of use, of a polymer containing polyoxyalkylene backbone units are disclosed, as well as the preparation thereof and methods of treating vision defects therewith.
Inventors
- 👤 Kai C. Su
- 👤 Frank F. Molock
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 08:28
CPC Classifications
G; G02; G02B; G02B1/00; G02B1/04; G02B1/041; G02B1/043; C; C08; C08G; C08G65/00; C08G65/02; C08G65/32; C08G65/329
Claims Analysis
Total Claims: 26
Claim 1
Independent Claim
319 words
An optically clear, wettable, flexible, hydrolytically stable, biologically inert, substantially siloxane-free, substantially non-swellable in ocular tear fluid, and oxygen permeable ophthalmic device fabricated from a crosslinkable polymer having units of the formula I ##STR19## wherein each b, d and f is independently 0-4; q is a number from 1 to 1000; each x, y and z is independently 0 to a number such that (x+y+z) times q =4 to 1000; each of R 1 -R 18 are selected from the group consisting of hydrogen, an aliphatic, aromatic or alicyclic containing radical, each optionally interrupted by a heteroatom provided no carbon atom in said unit is geminally bound to oxygen atoms; or 2 adjacent groups R 1 -R 18 , together with the atoms to which they are attached can form a 5-8 membered ring, and R 1 -R 18 may be further selected from or have a substituent selected from crosslinkable moieties provided that no carbon atoms bearing geminal oxygen atoms results and the terminal oxygen within a unit of formula I may be replaced by --NR 19 -- wherein R 19 is hydrogen, C 1-4 alkyl, or phenyl, provided that when b, d and f are all 0, at lest one of R 1 , R 2 , R 5 -R 8 , R 11 -R 14 , R 17 and R 18 in at least a portion of the units of formula I is other than hydrogen and such R 1 , R 2 , R 5 -R 8 , R 11 -R 14 , R 17 and R 18 individually or in the aggregate s sufficiently hydrophobic such that the resulting polymer is substantially non-swellable in water; said ophthalmic device having a receding contact angle with distilled water of less than 60° when measured at 20° C.; contains less than about 10% water; and having an oxygen permeability, Dk (×10 -10 ), greater than about 7.
Claim 2
Dependent Claim
319 words
An optically clear, wettable, flexible, hydrolytically stable, biologically inert, substantially siloxane-free, substantially non-swellable in ocular tear fluid, and oxygen permeable ophthalmic device fabricated from a crosslinkable polymer having units of the formula I ##STR19## wherein each b, d and f is independently 0-4; q is a number from 1 to 1000; each x, y and z is independently 0 to a number such that (x+y+z) times q =4 to 1000; each of R 1 -R 18 are selected from the group consisting of hydrogen, an aliphatic, aromatic or alicyclic containing radical, each optionally interrupted by a heteroatom provided no carbon atom in said unit is geminally bound to oxygen atoms; or 2 adjacent groups R 1 -R 18 , together with the atoms to which they are attached can form a 5-8 membered ring, and R 1 -R 18 may be further selected from or have a substituent selected from crosslinkable moieties provided that no carbon atoms bearing geminal oxygen atoms results and the terminal oxygen within a unit of formula I may be replaced by --NR 19 -- wherein R 19 is hydrogen, C 1-4 alkyl, or phenyl, provided that when b, d and f are all 0, at lest one of R 1 , R 2 , R 5 -R 8 , R 11 -R 14 , R 17 and R 18 in at least a portion of the units of formula I is other than hydrogen and such R 1 , R 2 , R 5 -R 8 , R 11 -R 14 , R 17 and R 18 individually or in the aggregate s sufficiently hydrophobic such that the resulting polymer is substantially non-swellable in water; said ophthalmic device having a receding contact angle with distilled water of less than 60° when measured at 20° C.; contains less than about 10% water; and having an oxygen permeability, Dk (×10 -10 ), greater than about 7.
Claim 3
Dependent Claim
635 words
The device of claim 1 wherein each of R 1 , R 2 , R 5 -R 8 , R 11 -R 14 , R 17 and R 18 are independently selected from the group consisting of unsubstituted (C 1 -C 16 ) alkyl; substituted C 1 -C 16 alkyl; unsubstituted C 2 -C 16 alkenyl; and substituted C 2 -C 16 alkenyl; wherein the alkyl and alkenyl substituents are independently selected from C 1 -C 16 alkoxycarbonyl, C 2 -C 16 alkenyloxycarbonyl, fluoro, aryl of up to 10 carbon atoms, C 1 -C 8 alkoxy, C 2 -C 6 alkanoyloxy, aryloxy of up to 10 carbon atoms, C 3 -C 6 alkenoyloxy, aroyloxy of up to 11 carbon atoms, C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkyloxy, C 3 -C 8 cycloalkyl-carbonyloxy, C 3 -C 8 cycloalkoxy-carbonyl, oxyacycloalkyl of up to 7 carbon atoms, axacycloalkoxy of up to 7 carbon atoms, oxacycloalkoxy (up to 7 carbon atoms)-carbonyl, oxacycloalkyl (up to 7 carbon atoms)-carbonyloxy, and aryl (of up to 10 carbon atoms)-oxycarbonyl, each of said alkyl and alkenyl substituents being, in turn, optionally substituted by C 1 -C 6 alkyl, fluoro or a C 1 -C 6 alkoxy provided said last mentioned alkoxy is not bound to a carbon atom already singly bound to another oxygen atom; R 1 , R 2 , R 5 -R 8 , R 11 -R 14 , R 17 and R 18 being further independently selected from aryl of up to 10 carbon atoms, C 3 -C 8 cycloalkyl, and oxacycloalkyl of up to 7 carbon atoms, each of which may be unsubstituted or further substituted with a substituent selected from the group of substituents for said alkyl set forth above; R 3 , R 4 , R 9 , R 10 , R 15 and R 16 are selected from the same group set forth above for R 1 ; and R 3 , R 4 , R 9 , R 10 , R 15 and R 16 are further independently selected from C 1 -C 16 alkoxycarbonyl, C 2 -C 16 alkanoyloxy, C 2 -C 16 alkenoxycarbonyl, and C 3 -C 16 alkanoyloxy, each of which may be further substituted by fluoro, aryl of up to 10 carbon atoms, or C 1 -C 16 alkoxy, and R 3 , R 4 , R 9 , R 10 , R 15 and R 16 are still further independently selected from aryloxy of up to 10 carbon atoms, cycloalkoxy of up to 8 carbon atoms, cycloalkyl (of up to 8 carbon atoms)-carbonyloxy, cycloalkoxy (of up to 8 carbon atoms)-carbonyl, aroyloxy of up to 11 carbon atoms, oxacycloalkoxy of up to 7 carbon atoms, oxacycloalkenoxy of up to 7 carbon atoms, oxacycloalkoxy (of up to 7 carbon atoms)-carbonyl, oxacycloalkyl (of up to 7 carbon atoms)carbonyloxy, oxacycloalkenyloxy (of up to 7 carbon atoms)-carbonyl, and aryloxy (of up to 10 carbon atoms)carbonyl, each of which may be further substituted by fluoro, C 1 -C 6 alkyl or C 1 -C 6 alkoxy, provided that any substituent having an oxygen atom as its link to the rest of the molecule may not be a substituent on the same carbon atom which is singly bonded to another oxygen atom; or 2 adjacent groups R 1 -R 18 , together with the atoms to which they are attached may form a 5-8 membered cycloalkyl or bicycloalkyl or a 5-8 membered oxacycloalkyl provided that in said oxacycloalkyl formed by two of R 1 -R 18 , the ring oxygen atom is not bound to a carbon which is singly bound directly to another oxygen atom; and said R 1 -R 18 may further be selected from or have a substituent selected from crosslinkable moieties provided that no carbon atoms bearing geminal oxygen atoms result.
Claim 4
Dependent Claim
14 words
The device of claim 1 wherein said crosslinkable polymer is crosslinked up to 10%.
Claim 5
Dependent Claim
14 words
The device of claim 3 wherein said crosslinkable polymer is crosslinked up to 5%.
Claim 6
Dependent Claim
17 words
The device of claim 4 wherein said crosslinkable polymer is crosslinked from about 1 to about 4%.
Claim 7
Dependent Claim
17 words
The device of claim 5 wherein said crosslinkable polymer is crosslinked from about 2 to about 3%.
Claim 8
Dependent Claim
14 words
The device of claim 1 wherein said receding contact angle is less than 40°.
Claim 9
Dependent Claim
14 words
The device of claim 7 wherein said receding contact angle is less than 25°.
Claim 10
Dependent Claim
14 words
The device of claim 8 wherein said receding contact angle is less than 15°.
Claim 11
Dependent Claim
14 words
The device of claim 8 wherein said receding contact angle is less than 10°.
Claim 12
Dependent Claim
17 words
The device of claim 1 wherein said unit of formula I is at least 25% halogen free.
Claim 13
Dependent Claim
17 words
The device of claim 11 wherein said unit of formula I is at least 30% halogen free.
Claim 14
Dependent Claim
17 words
The device of claim 12 wherein said unit of formula I is at least 40% halogen free.
Claim 15
Dependent Claim
15 words
The device of claim 13 wherein said unit of formula I is substantially halogen free.
Claim 16
Dependent Claim
13 words
The device of claim 1 wherein said oxygen permeability is greater than 15.
Claim 17
Dependent Claim
13 words
The device of claim 15 wherein said oxygen permeability is greater than 20.
Claim 18
Dependent Claim
13 words
The device of claim 16 wherein said oxygen permeability is greater than 40.
Claim 19
Dependent Claim
14 words
The device of claim 1 wherein each b, d and f is independently 0-3.
Claim 20
Dependent Claim
14 words
The device of claim 18 wherein each b, d and f is independently 0-2.
Claim 21
Dependent Claim
16 words
The device of claim 19 wherein each b, d and f is independently 0 or 1.
Claim 22
Dependent Claim
10 words
The device of claim 1 which is a contact lens.
Claim 23
Dependent Claim
27 words
The device of claim 1 wherein b, d and f are each 0 or 1 and R 1 -R 18 are independently selected from hydrogen and methyl.
Claim 24
Dependent Claim
261 words
An optically clear, wettable, flexible, hydrolytically stable, biologically inert, substantially siloxane free, substantially non-swellable in ocular tear fluid, and oxygen permeable ophthalmic device according to claim 1 fabricated from a crosslinked polymer of a monomer of the formula L'--D--[A--L--D--].sub.w A--L" (II) wherein w is 0-8; each D is independently --O-- or --N(R 19 )--; each R 19 is independently H, C 1 -C 4 alkyl, or phenyl; each L is independently --BRB'--; each B and B' is independently ##STR20## wherein the carbonyl group is bound to said D or said A; each R is a divalent linking group selected from C 1 -C 25 aliphatic C 5 -C 7 membered cycloaliphatic having 5-25 carbon atoms; aralkyl or alkaryl having 7-25 carbon atoms wherein the aliphatic and alkyl groups can be optionally interrrupted by ##STR21## and the aryl and arylene groups are unsuhstituted or further substituted with a substituent selected from halogen, C 1 -C 4 alkyl and C 1 -C 12 perhaloalkyl; L' is selected from H, P'--R--B'-- and P'--B--R--B'-- wherein B, R and B' are as defined above and P' is H or a moiety capable of being bound to the carbonyl of ##STR22## and containing a group capable of undergoing crosslinking when coreacted with a crosslinking agent or when irradiated by actinic radiation; L" is selected from H, a terminal monovalent aliphatic, aromatic or cycloaliphatic group of up to 14 carbon atoms, --B--R--P' and --BRB'P' wherein B, R, B' and P' are as defined above; and each A is a unit of the formula I according to claim 1.
Claim 25
Dependent Claim
50 words
The device of claim 23 fabricated from a crosslinked polymer of a monomer of formula II which is crosslinked in the presence of up to 10% by weight of an additional vinylic comonomer selected from N-(vinyl containing moiety)-pyrrolidone and (vinyl containing ##STR23## with R being H or CH 3 .
Claim 26
Dependent Claim
74 words
The device of claim 23 wherein each b, d and f are independently 0 or 1; each R 1 -R 18 is independently selected from hydrogen and methyl; B and B' are each ##STR24## R is phenylene or D is --O--; L' is P'--R'--B'; L" is --B--R'--P'; R' is phenylene, toluylene, or -(phenyl or toluyl)-amino-carbonyloxyethyl-, the phenyl ring of said R' being bound to said B or B' and P' is vinyl or methacroyloxy.
References Cited (Backward Citations)
US3786034A
Cited
US4379864A
Cited
US4304489A
Cited
US4275183A
Cited
US4465794A
Cited
US4634722A
Cited
US4440918A
Cited
US4463149A
Cited
US4546123A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-10-25 | 1992-04-25 | 1992-10-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-10-25 | 1996-04-25 | 1996-10-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-10-25 | 2000-04-25 | 2000-10-25 | $7700.00 | Window Closed / Lapsed |